Related Experiment Video

Updated: Jun 25, 2025

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

10.7K

Ubiquitous regulation of cerebrovascular diseases by ubiquitin-modifying enzymes

Jingyong Huang1, Zhenhu Zhu2, Dirk Schlüter3

  • 1Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Clinical and Translational Medicine
|May 23, 2024
PubMed

Insights

Ubiquitin-modifying enzymes (UMEs) are crucial in regulating cerebrovascular diseases (CVDs). Targeting UMEs and related therapies offers promising new avenues for treating conditions like stroke and atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Cerebrovascular diseases (CVDs) pose a significant global health burden.
  • Understanding the molecular basis of CVDs is essential for developing effective treatments.
  • Ubiquitin-modifying enzymes (UMEs) have emerged as key regulators in CVD pathology.

Purpose of the Study:

  • To highlight the critical role of UMEs in the pathogenesis of various CVDs.
  • To explore UMEs as potential therapeutic targets for cerebrovascular disorders.
  • To discuss the future implications of UME-targeting strategies in CVD treatment.

Main Methods:

  • Review of existing literature on UMEs and their involvement in CVDs.
  • Analysis of the regulatory functions of ubiquitination in cerebrovascular pathologies.
  • Exploration of novel therapeutic modalities based on UME modulation.

Main Results:

  • UMEs play a significant role in regulating pathological processes in ischemic stroke, hemorrhagic stroke, moyamoya disease, and atherosclerosis.
  • UMEs are implicated in diverse cellular functions critical to cerebrovascular health.
  • The ubiquitination machinery is a central player in the molecular landscape of CVDs.

Conclusions:

  • UMEs represent promising druggable targets for the development of novel therapies for CVDs.
  • Advanced techniques like proteolysis-targeting chimera and deubiquitinase-targeting chimera hold potential for revolutionizing CVD treatment.
  • Further research into UME functions could unlock new preventative and therapeutic strategies for cerebrovascular diseases.
Keywords:
cerebrovascular diseasedeubiquitinating enzymedisease mechanismtherapeutic targetubiquitinating enzymeubiquitination

More Related Videos

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay07:05

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

444
Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples09:45

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Published on: May 10, 2015

9.7K

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
830
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
892
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
47.2K